Corbus Pharmaceuticals Holdings (LTS:0SZI) Tax Rate %: 0.00% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0SZI Corbus Pharmaceuticals Holdings Inc LTS:0SZI
34 GF Score
Price $9.64
! 1 Warning Sign
View Full Analysis

What is Corbus Pharmaceuticals Holdings Tax Rate %?

Corbus Pharmaceuticals Holdings LTS:0SZI +0.52% 34 Tax Rate % is 0.00% as of Jun. 2026. GuruFocus rates LTS:0SZI with a GF Score™ of 34/100. The stock has 1 warning sign investors should review.

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Corbus Pharmaceuticals Holdings's Tax Expense for the three months ended in Jun. 2026 was $0.00 Mil. Corbus Pharmaceuticals Holdings's Pre-Tax Income for the three months ended in Jun. 2026 was $-35.04 Mil. Therefore, Corbus Pharmaceuticals Holdings's Tax Rate % for the quarter that ended in Jun. 2026 was 0.00%.

Corbus Pharmaceuticals Holdings Tax Rate % Related Terms

Corbus Pharmaceuticals Holdings Tax Rate % Historical Data

* Premium members only.

The historical data trend for Corbus Pharmaceuticals Holdings's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Corbus Pharmaceuticals Holdings Tax Rate % Chart

Corbus Pharmaceuticals Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Tax Rate %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Corbus Pharmaceuticals Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Tax Rate % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
LTS:0SZI
34GF Score
Corbus Pharmaceuticals Holdings Inc LTS:0SZI
Tax Rate % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Corbus Pharmaceuticals Holdings Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Corbus Pharmaceuticals Holdings's Tax Rate % for the fiscal year that ended in Dec. 2025 is calculated as

Tax Rate %=Tax Expense (A: Dec. 2025 )/Pre-Tax Income (A: Dec. 2025 )
=0/-78.537
=0.00 %

Corbus Pharmaceuticals Holdings's Tax Rate % for the quarter that ended in Jun. 2026 is calculated as

Tax Rate %=Tax Expense (Q: Jun. 2026 )/Pre-Tax Income (Q: Jun. 2026 )
=0/-35.037
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Rate % →
What does a Tax Rate % of 0.00% mean?
Corbus Pharmaceuticals Holdings (LTS:0SZI) has a Tax Rate % of 0.00% as of Jun. 2026.
Is Corbus Pharmaceuticals Holdings' Tax Rate % too high?
Corbus Pharmaceuticals Holdings' current Tax Rate % is 0.00%. Overall, Corbus Pharmaceuticals Holdings has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Corbus Pharmaceuticals Holdings' Tax Rate % compare to OKUR and HUMA?
Corbus Pharmaceuticals Holdings' Tax Rate % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Rate % for a Biotechnology company?
A good Tax Rate % depends on the Biotechnology industry context. However, Tax Rate % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Rate % mean?
A high Tax Rate % can signal that a stock is expensive relative to its fundamentals. Corbus Pharmaceuticals Holdings's current Tax Rate % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Corbus Pharmaceuticals Holdings stock overvalued right now?
Corbus Pharmaceuticals Holdings (LTS:0SZI) has a current Tax Rate % of 0.00%. The current Tax Rate % is 0.00%. Corbus Pharmaceuticals Holdings' overall GF Score™ is 34/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Rate % calculated?
Tax Rate % is calculated from a company's financial statements. For Corbus Pharmaceuticals Holdings (LTS:0SZI), the current Tax Rate % is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Corbus Pharmaceuticals Holdings Business Description

Other Exchanges CRBP:USA3371:Germany
Address 500 River Ridge Drive, Norwood, MA, USA, 02062
Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
34GF Score

Get the complete analysis for LTS:0SZI

Tax Rate % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.64
Price